期刊文献+

早期宫颈癌子宫切除术后HR⁃HPV清除及其影响因素研究 被引量:3

Observation and influencing factors of HR⁃HPV clearance after hysterectomy in early cervical cancer
下载PDF
导出
摘要 目的探讨早期宫颈癌子宫切除术后高危型人乳头瘤病毒(HR⁃HPV)清除情况及其影响因素。方法回顾性分析2017年5月至2020年5月在河北北方学院附属第一医院因早期宫颈癌行子宫切除术的100例患者临床资料。根据HR⁃HPV清除情况,将患者分为清除组(81例)和未清除组(19例)。统计HR⁃HPV清除情况及其影响因素,并用Logistic逐步回归分析HR-HPV未清除的影响因素。结果术后100例患者中HR⁃HPV清除81例,清除率为81.00%(81/100);未清除为19例,未清除率为19.00%(19/100)。未清除组中年龄≥55岁、首次性交年龄<20岁、淋巴结转移、性伴侣人数≥2人、孕次≥2次、术后未接受辅助治疗、肿瘤浸润深度较深的人数占比均高于清除组(P<0.05)。多因素Logistic回归分析表明,年龄≥55岁、首次性交年龄<20岁、淋巴结转移、性伴侣人数≥2人、孕次≥2次、术后未接受辅助治疗、肿瘤浸润深度较深均是早期宫颈癌子宫切除术后HR⁃HPV未清除的危险因素(P<0.05)。结论早期宫颈癌子宫切除术后患者的年龄、首次性交年龄、淋巴结转移、性伴侣人数、孕次、术后辅助治疗、肿瘤浸润深度等是HR⁃HPV未能完全清除的影响因素。针对这些因素,应采取有效的措施进行干预,以提高术后HR⁃HPV的完全清除率。 Objective To investigate the clearance of high⁃risk human papillomavirus(HR⁃HPV)after hysterectomy in the patients with early cervical cancer and its influencing factors.Methods The clinical data of 100 patients who underwent hysterectomy for early cervical cancer in the First Affiliated Hospital of Hebei North University from May 2017 to May 2020 were retrospectively analyzed.The patients were divided into the cleared group(n=81)and the uncleared group(n=19)by the HR⁃HPV elimination.The clearance of HR⁃HPV virus and related influencing factors were analyzed,and the influencing factors of virus failure were analyzed by Logistic stepwise regression.Results Of the 100 patients after surgery,81 were cleared of HPV,with a clearance rate of 81.00%(81/100),and 19 were not cleared,with a non⁃clearance rate of 19.00%(19/100).The age of the non⁃cleared group was≥55 years old and the age of having first sexual intercourse was<20 years old.Lymph node metastasis,the number of sexual partners≥2,the number of pregnancies≥2,the proportion of the patients who did not receive adjuvant treatment after surgery and the depth of tumor infiltration were all higher or greater than those of the cleared group(P<0.05).Multivariate Logistic regression analysis showed that age≥55 years,age of having first sexual intercourse<20 years old and other indexes were all risk factors of non⁃cleared HR⁃HPV after hysterectomy in treatement of early cervical cancer(P<0.05).Conclusion The patients with early cervical cancer after hysterectomy were influenced by age,age of having first sexual intercourse,lymph node metastasis,the number of sexual partners,the number of pregnancies,the depth of tumor infiltration,postoperative adjuvant therapy after surgery and other factors,resulting in incomplete clearance of HR HPV.In light of these factors,effective measures should be taken,so as to improve the rate of complete clearance of HR⁃HPV after surgery.
作者 曹君阳 张玉虹 陈江平 Cao Junyang;Zhang Yuhong;Chen Jiangping(Department of Obstetrics and Gynecology,First Affiliated Hospital of Hebei North University,Zhangjiakou 075000,China)
出处 《海军医学杂志》 2023年第4期388-391,共4页 Journal of Navy Medicine
基金 河北省财政厅临床医学优秀人才培养研究项目(2022-361009)。
关键词 早期宫颈癌 子宫切除术 生殖道高危型人乳头瘤病毒 病毒清除 影响因素 Early cervical cancer Hysterectomy Genital high⁃risk human papillomavirus Virus clearance Influencing factor
  • 相关文献

参考文献14

二级参考文献151

  • 1李会影,杨丽萍,周津曼,韩凌宇.派特灵在下生殖道高危型HPV16感染治疗中的临床应用研究[J].世界最新医学信息文摘,2020(95):109-110. 被引量:1
  • 2杨丽萍,沙丽,周津曼,韩凌宇,李会影.派特灵在下生殖道高危型HPV16、18感染治疗中的临床应用研究[J].世界最新医学信息文摘,2020(55):118-119. 被引量:3
  • 3周坚红,谢幸.生殖道人乳头状瘤病毒感染后子宫颈局部免疫反应的变化[J].中华妇产科杂志,2004,39(7):497-499. 被引量:6
  • 4Jemal A,Siegel R,Ward E. Cancer Statistics,2007[J].{H}CA-A Cancer Journal for Clinicians,2007.43-66.
  • 5Howe HL,Wu X,Ries LA. Annual report to the nation on the status of cancer,1975-2003,featuring cancer among U.S.Hispanic/Latino populations[J].{H}CANCER,2006,(08):1711-1742.
  • 6Sherman ME,Wang SS,Carreon J. Mortality trends for cervical squamous and adenocarcinoma in the United States.Relation to incidence and survival[J].{H}CANCER,2005,(06):1258-1264.
  • 7Parkin DM,Bray F,Ferlay J. Global cancer statistics,2002[J].{H}CA-A Cancer Journal for Clinicians,2005.74-108.
  • 8Kamangar F,Dores GM,Anderson WF. Patterns of cancer incidence,mortality,and prevalence across five continents:defining priorities to reduce cancer disparities in different geographic regions of the world[J].{H}Journal of Clinical Oncology,2006,(14):2137-2150.
  • 9Villa LL,Costa RL,Petta CA. Prophylactic quadrivalent human papillomavirus(types 6,11,16,and 18)L1 virus-like particle vaccine in young women:a randomized double-blind placebo-controlled multicentre phase II efifcacy trial[J].{H}LANCET ONCOLOGY,2005.271-278.
  • 10Ault KA,Future II Study Group. Effect of prophylactic human papillomavirus L1 virus-like-particle vaccine on risk of cervical intraepithelial neoplasia grade 2,grade 3,and adenocarcinoma in situ:a combined analysis of four randomised clinical trials[J].{H}LANCET,2007,(9576):1861-1868.

共引文献369

同被引文献29

引证文献3

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部